Corporate News     22-May-24
Board of Strides Pharma Science recommends final dividend
Of Rs 2.5 per share
Strides Pharma Science announced that the Board of Directors of the Company at its meeting held on 22 May 2024, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.
Previous News
  Strides Pharma hits record high after arm gets USFDA nod for antidepressant drug
 ( Hot Pursuit - 16-Sep-24   15:53 )
  Strides receives USFDA approval for Fluoxetine Tabs 60 mg
 ( Corporate News - 16-Sep-24   15:22 )
  Strides secures approval of shareholders and creditors for creation of OneSource
 ( Corporate News - 11-Sep-24   14:48 )
  Strides Pharma Science schedules AGM
 ( Corporate News - 06-Sep-24   16:39 )
  Strides Pharma hits record high as arm gets USFDA nod for asthma drug
 ( Hot Pursuit - 06-Sep-24   10:45 )
  Strides Pharma Science receives USFDA approval for generic version of Theophylline ER Tablets 300 mg and 540 mg
 ( Corporate News - 06-Sep-24   10:17 )
  Strides Pharma Science fixes record date for final dividend
 ( Market Beat - Reports 22-Aug-24   15:57 )
  Nifty above 24,550 mark; broader mkt outperforms
 ( Market Commentary - Mid-Session 19-Aug-24   13:30 )
  Barometers trade sideways; Oil & gas shares advance
 ( Market Commentary - Mid-Session 19-Aug-24   12:40 )
  Strides Pharma arm gets EIR from USFDA for Chennai facility
 ( Hot Pursuit - 19-Aug-24   11:20 )
  Strides Alathur successfully concludes USFDA inspection
 ( Corporate News - 19-Aug-24   11:17 )
Other Stories
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
Back Top